Market Closed -
Xetra
16:35:09 29/04/2024 BST
|
After market
19:12:20
|
27.68
EUR
|
+1.73%
|
|
27.56
|
-0.42%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
27,969
|
21,095
|
19,769
|
14,785
|
15,810
|
15,326
|
-
|
-
|
Enterprise Value (EV)
1 |
53,573
|
45,171
|
44,160
|
39,799
|
15,810
|
29,598
|
28,806
|
26,317
|
P/E ratio
|
14.8
x
|
12.4
x
|
10.9
x
|
10.8
x
|
-
|
10.4
x
|
8.54
x
|
7.98
x
|
Yield
|
1.67%
|
2.33%
|
2.6%
|
3.5%
|
-
|
3.43%
|
3.89%
|
4.29%
|
Capitalization / Revenue
|
0.79
x
|
0.58
x
|
0.53
x
|
0.36
x
|
0.71
x
|
0.67
x
|
0.64
x
|
0.61
x
|
EV / Revenue
|
1.51
x
|
1.25
x
|
1.18
x
|
0.97
x
|
0.71
x
|
1.29
x
|
1.2
x
|
1.05
x
|
EV / EBITDA
|
7.54
x
|
6.33
x
|
6.47
x
|
6.32
x
|
4.62
x
|
7.91
x
|
7.11
x
|
6.04
x
|
EV / FCF
|
49.6
x
|
18.2
x
|
37
x
|
17.4
x
|
-
|
22.8
x
|
20.2
x
|
16.4
x
|
FCF Yield
|
2.02%
|
5.49%
|
2.7%
|
5.73%
|
-
|
4.39%
|
4.94%
|
6.11%
|
Price to Book
|
1.67
x
|
1.24
x
|
1.04
x
|
0.72
x
|
-
|
0.75
x
|
0.71
x
|
0.69
x
|
Nbr of stocks (in thousands)
|
557,380
|
557,472
|
558,454
|
563,237
|
563,237
|
563,237
|
-
|
-
|
Reference price
2 |
50.18
|
37.84
|
35.40
|
26.25
|
28.07
|
27.21
|
27.21
|
27.21
|
Announcement Date
|
20/02/20
|
23/02/21
|
22/02/22
|
04/03/23
|
21/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
35,409
|
36,277
|
37,520
|
40,840
|
22,299
|
22,959
|
24,060
|
25,178
|
EBITDA
1 |
7,104
|
7,132
|
6,825
|
6,294
|
3,422
|
3,742
|
4,051
|
4,355
|
EBIT
1 |
4,599
|
4,612
|
4,252
|
4,004
|
2,262
|
2,449
|
2,740
|
2,982
|
Operating Margin
|
12.99%
|
12.71%
|
11.33%
|
9.8%
|
10.14%
|
10.67%
|
11.39%
|
11.84%
|
Earnings before Tax (EBT)
1 |
3,912
|
3,726
|
3,652
|
2,814
|
-
|
2,058
|
2,270
|
2,477
|
Net income
1 |
1,883
|
1,707
|
1,818
|
1,372
|
-
|
1,451
|
1,784
|
1,923
|
Net margin
|
5.32%
|
4.71%
|
4.85%
|
3.36%
|
-
|
6.32%
|
7.41%
|
7.64%
|
EPS
2 |
3.380
|
3.060
|
3.260
|
2.440
|
-
|
2.619
|
3.185
|
3.412
|
Free Cash Flow
1 |
1,081
|
2,478
|
1,193
|
2,281
|
-
|
1,298
|
1,423
|
1,608
|
FCF margin
|
3.05%
|
6.83%
|
3.18%
|
5.59%
|
-
|
5.65%
|
5.92%
|
6.39%
|
FCF Conversion (EBITDA)
|
15.22%
|
34.74%
|
17.48%
|
36.24%
|
-
|
34.69%
|
35.14%
|
36.93%
|
FCF Conversion (Net income)
|
57.41%
|
145.17%
|
65.62%
|
166.25%
|
-
|
89.49%
|
79.78%
|
83.64%
|
Dividend per Share
2 |
0.8400
|
0.8800
|
0.9200
|
0.9200
|
-
|
0.9328
|
1.060
|
1.167
|
Announcement Date
|
20/02/20
|
23/02/21
|
22/02/22
|
04/03/23
|
21/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S1
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
18,055
|
18,230
|
9,324
|
9,966
|
9,720
|
10,018
|
10,459
|
10,643
|
10,225
|
10,359
|
5,518
|
5,678
|
5,703
|
5,778
|
5,720
|
5,863
|
-
|
EBITDA
1 |
-
|
-
|
1,667
|
1,868
|
1,658
|
-
|
1,658
|
-
|
1,585
|
1,649
|
-
|
-
|
633.7
|
-
|
-
|
-
|
-
|
EBIT
1 |
2,248
|
2,039
|
1,041
|
1,166
|
996
|
1,003
|
949
|
1,052
|
908
|
956
|
519
|
634
|
621
|
635.6
|
601.9
|
630.1
|
-
|
Operating Margin
|
12.45%
|
11.18%
|
11.16%
|
11.7%
|
10.25%
|
10.01%
|
9.07%
|
9.88%
|
8.88%
|
9.23%
|
9.41%
|
11.17%
|
10.89%
|
11%
|
10.52%
|
10.75%
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
882
|
1,001
|
784
|
729
|
551
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-
|
906
|
413
|
499
|
413
|
383
|
321
|
255
|
346
|
80
|
-406
|
-
|
288.3
|
297.1
|
283.5
|
200.3
|
-
|
Net margin
|
-
|
4.97%
|
4.43%
|
5.01%
|
4.25%
|
3.82%
|
3.07%
|
2.4%
|
3.38%
|
0.77%
|
-7.36%
|
-
|
5.06%
|
5.14%
|
4.96%
|
3.42%
|
-
|
EPS
2 |
1.560
|
1.620
|
0.7400
|
0.9000
|
0.7400
|
0.6800
|
0.5700
|
0.4500
|
0.6100
|
0.1500
|
-0.7200
|
-
|
0.6248
|
0.6526
|
0.5011
|
0.3541
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
0.9200
|
-
|
-
|
-
|
0.9200
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
0.9200
|
-
|
Announcement Date
|
30/07/20
|
30/07/21
|
02/11/21
|
22/02/22
|
04/05/22
|
02/08/22
|
01/11/22
|
04/03/23
|
09/05/23
|
02/08/23
|
02/11/23
|
21/02/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
25,604
|
24,076
|
24,391
|
25,014
|
-
|
14,272
|
13,480
|
10,991
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.604
x
|
3.376
x
|
3.574
x
|
3.974
x
|
-
|
3.814
x
|
3.328
x
|
2.524
x
|
Free Cash Flow
1 |
1,081
|
2,478
|
1,193
|
2,281
|
-
|
1,298
|
1,423
|
1,608
|
ROE (net income / shareholders' equity)
|
11.3%
|
10.1%
|
10.1%
|
8.5%
|
-
|
7.77%
|
8.26%
|
8.37%
|
ROA (Net income/ Total Assets)
|
3.19%
|
2.55%
|
2.62%
|
2.33%
|
-
|
2.55%
|
2.94%
|
3.56%
|
Assets
1 |
58,973
|
66,826
|
69,305
|
58,871
|
-
|
56,928
|
60,729
|
53,947
|
Book Value Per Share
2 |
30.10
|
30.40
|
34.00
|
36.20
|
-
|
36.50
|
38.60
|
39.30
|
Cash Flow per Share
2 |
6.310
|
11.70
|
9.100
|
7.480
|
-
|
4.420
|
4.850
|
5.350
|
Capex
1 |
2,433
|
2,366
|
2,017
|
1,917
|
-
|
1,197
|
1,254
|
1,310
|
Capex / Sales
|
6.87%
|
6.52%
|
5.38%
|
4.69%
|
-
|
5.22%
|
5.21%
|
5.2%
|
Announcement Date
|
20/02/20
|
23/02/21
|
22/02/22
|
04/03/23
|
21/02/24
|
-
|
-
|
-
|
Last Close Price
27.21
EUR Average target price
36.22
EUR Spread / Average Target +33.11% Consensus |
1st Jan change
|
Capi.
|
---|
| -1.39% | 16.36B | | -14.79% | 84.68B | | +14.50% | 81.12B | | +10.49% | 29.59B | | -9.71% | 16.73B | | -31.58% | 11.77B | | +1.82% | 11.72B | | +31.73% | 11.71B | | -0.47% | 11.66B | | -7.30% | 11.37B |
Other Healthcare Facilities & Services
|